Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bulbo-Spinal Atrophy, X-Linked”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Testing effectiveness (Phase 2)Study completedNCT05694819
What this trial is testing

Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)

Who this might be right for
Salivary Gland Cancer
National Cancer Center Hospital East 57
Early research (Phase 1)Ended earlyNCT05241613
What this trial is testing

AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc 28
Testing effectiveness (Phase 2)UnknownNCT06108193
What this trial is testing

Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris

Who this might be right for
Acne Vulgaris
Chang Gung Memorial Hospital 26
Not applicableStudy completedNCT01977313
What this trial is testing

Genetic Polymorphism of the Androgen Receptor-Gene and Sexual Function in Middle Aged Women

Who this might be right for
LibidoReceptors, AndrogenPolymorphism, Genetic+1 more
Insel Gruppe AG, University Hospital Bern 45
Testing effectiveness (Phase 2)Looking for participantsNCT07190300
What this trial is testing

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Novartis Pharmaceuticals 155
Testing effectiveness (Phase 2)Study completedNCT00004771
What this trial is testing

Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease

Who this might be right for
Spinal Muscular AtrophyAmyotrophic Lateral SclerosisSpinobulbar Muscular Atrophy
National Center for Research Resources (NCRR) 40
Early research (Phase 1)Study completedNCT07105371
What this trial is testing

Patients With ALS and Other Motor Disorders Will be Treated With Mesenchymal Cell Exosome Solution

Who this might be right for
Motor Disorders
The Foundation for Orthopaedics and Regenerative Medicine 18
Not applicableWithdrawnNCT05062174
What this trial is testing

Breast Cancer BRCA1 Carriers: a Pilot Study

Who this might be right for
BRCA1 MutationHigh-grade Serous Ovarian CancerTNBC - Triple-Negative Breast Cancer
Indiana University
Testing effectiveness (Phase 2)Study completedNCT03437941
What this trial is testing

Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Corcept Therapeutics 39
Not applicableActive Not RecruitingNCT07443449
What this trial is testing

International SBMA Project (KDA)

Who this might be right for
SBMASpinal and Bulbar Muscular Atrophy (SBMA)
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 700
Not applicableStudy completedNCT02501395
What this trial is testing

MRI in Patients With Kennedy Disease

Who this might be right for
Bulbo-Spinal Atrophy, X-LinkedKennedy Disease
Rigshospitalet, Denmark 53
Testing effectiveness (Phase 2)Study completedNCT00365599
What this trial is testing

Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 43
Testing effectiveness (Phase 2)Ended earlyNCT02348281
What this trial is testing

Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients

Who this might be right for
Breast Cancer
Fudan University 1
Testing effectiveness (Phase 2)Study completedNCT05517603
What this trial is testing

Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients

Who this might be right for
Spinal and Bulbar Muscular AtrophyKennedy's Disease
AnnJi Pharmaceutical Co., Ltd. 25
Testing effectiveness (Phase 2)Study completedNCT01369901
What this trial is testing

Effect of Functional Exercise in Patients With Spinal Bulbar Muscular Atrophy

Who this might be right for
Motor Neuron Disease
National Institute of Neurological Disorders and Stroke (NINDS) 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT04090528
What this trial is testing

PTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerMetastatic CancerProstate Cancer
University of Wisconsin, Madison 60
Testing effectiveness (Phase 2)Ended earlyNCT04926181
What this trial is testing

Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer

Who this might be right for
Small Cell Neuroendocrine CarcinomaProstate CancerSmall Cell Carcinoma
Rahul Aggarwal 2
Testing effectiveness (Phase 2)Study completedNCT02024932
What this trial is testing

Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy

Who this might be right for
Spinal and Bulbar Muscular Atrophy
Novartis Pharmaceuticals 37
Not applicableLooking for participantsNCT03555578
What this trial is testing

Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"

Who this might be right for
Spinal and Bulbar Muscular Atrophy
Takeda 1,890
Large-scale testing (Phase 3)Study completedNCT05386680
What this trial is testing

Phase IIIb, Open-label, Multi-center Study to Evaluate Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally to Participants With SMA Who Discontinued Treatment With Nusinersen or Risdiplam

Who this might be right for
Spinal Muscular Atrophy
Novartis Pharmaceuticals 27
Load More Results